• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Ionis Pharmaceuticals

heart
Posted inClinical Trials, Metabolism

Merck & Co. Has Come Up With Very Powerful Pill Against ‘Bad’ Cholesterol

March 8, 2023March 8, 2023

MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.

Bepirovirsen: New Drug for Hepatitis B
Posted inClinical Trials, Infections

Bepirovirsen: New Drug for Hepatitis B

November 11, 2022November 11, 2022

Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.

brain
Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases

Qalsody: New Drug for Amyotrophic Lateral Sclerosis with SOD1 Mutation

August 2, 2022September 8, 2022

Tofersen and the mixed results of treatment for the deadly neurodegenerative disease.

Biogen to Develop Updated Version of Spinraza
Posted inNeuroscience, Pharma & Biotech, Rare/Orphan Diseases

Biogen to Develop Updated Version of Spinraza

January 5, 2022September 8, 2022

Nusinersen for the treatment of spinal muscular atrophy will get a follow-up.

Hypertension.
Posted inClinical Trials, Metabolism

Innovative Treatment for Hypertension: One Shot Every Quarter or Even Six Months

December 16, 2021September 8, 2022

Arterial hypertension is waiting for a major pharmacological breakthrough. Hundreds of millions of people will be saved.

Zolgensma: Gene Therapy That Cure Spinal Muscular Atrophy. The Most Comprehensive Review
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Zolgensma: Gene Therapy That Cure Spinal Muscular Atrophy. The Most Comprehensive Review

April 8, 2021September 8, 2022

Novartis revealed the most expensive drug in the world. And it is amazing.

BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News